Clinical research progress of ridaforolimus (AP23573, MK8668) over the past decade: a systemic review

Rapamycin, an established mTOR inhibitor in clinical practice, is widely recognized for its therapeutic efficacy. Ridaforolimus, a non-prodrug rapalog, offers improved aqueous solubility, stability, and affinity compared to rapamycin. In recent years, there has been a surge in clinical trials involv...

Full description

Saved in:
Bibliographic Details
Main Authors: Lumin Wang (Author), Qining Qiu (Author), Dawei Yang (Author), Chang Cao (Author), Yanqin Lu (Author), Yulan Zeng (Author), Weiwen Jiang (Author), Yun Shen (Author), Yanrong Ye (Author)
Format: Book
Published: Frontiers Media S.A., 2024-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available